ArticlemAbs
A recombinant triplebody with specificity for CD19 and HLA-DR mediates preferential binding to antigen double-positive cells by dual-targeting.
Ingo Schubert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
trialcites it